Switching to Conbercept in Diabetic Macular Edema After Unsatisfactory Response to Previous Intravitreal Injection of Ranibizumab

OBJECTIVE: To assess the functional and anatomical effects of transitioning to conbercept intravitreal injection (IVC) treatment in patients with diabetic macular edema (DME) who had inadequate responses to prior anti-vascular endothelial growth factor (anti-VEGF) injections. METHODS: We retrospecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Xing, Peiyu, Meng, Bo, Hu, Xiaojia, Qu, Wei, Wang, Shaowei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661898/
https://www.ncbi.nlm.nih.gov/pubmed/38026602
http://dx.doi.org/10.2147/OPTH.S431145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661898/
https://www.ncbi.nlm.nih.gov/pubmed/38026602
http://dx.doi.org/10.2147/OPTH.S431145

Ejemplares similares